Medicus Pharma (Medicus Pharma) Debt-to-Equity : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Medicus Pharma Debt-to-Equity?

Medicus Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Medicus Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Medicus Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $0.81 Mil. Medicus Pharma's debt to equity for the quarter that ended in Dec. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medicus Pharma's Debt-to-Equity or its related term are showing as below:

MDPLF' s Debt-to-Equity Range Over the Past 10 Years
Min: -0.13 Med: -0.1 Max: -0.06
Current: 2.89

During the past 3 years, the highest Debt-to-Equity Ratio of Medicus Pharma was -0.06. The lowest was -0.13. And the median was -0.10.

MDPLF's Debt-to-Equity is ranked worse than
96.25% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs MDPLF: 2.89

Medicus Pharma Debt-to-Equity Historical Data

The historical data trend for Medicus Pharma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicus Pharma Debt-to-Equity Chart

Medicus Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Debt-to-Equity

-0.06

-0.13

Medicus Pharma Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial				-0.13	-0.14	-0.18	-	-

Competitive Comparison of Medicus Pharma's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Medicus Pharma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Pharma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's Debt-to-Equity falls into.

Medicus Pharma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medicus Pharma's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.806
	=	0.00

Medicus Pharma's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.806
	=	0.00

Medicus Pharma (OTCPK:MDPLF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medicus Pharma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medicus Pharma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicus Pharma (Medicus Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicus Pharma Ltd (OTCPK:MDPLF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

MDCX:Canada

Address

100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

http://www.medicuspharma.com

Medicus Pharma Ltd will carry on the business of pharmaceutical drug development focused initially on SkinJect. The objective of SkinJect is developing and commercializing novel microneedle arrays for the purpose of treating certain skin cancers, initially basal cell carcinoma.

Medicus Pharma (Medicus Pharma) Headlines

From GuruFocus

Medicus Pharma Opens the Market

By PRNewswire • 10-26-2023